Stayble Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-09 | Stayble Therapeutics AB | Andreas Gerward | VD | Loan granted | 30 000 | 0 | SEK | 0 | 2020-03-05 |
| 2020-07-17 | Stayble Therapeutics AB | Erik Kinnman | Styrelseledamot/suppleant | Acquisition | 1 744 | 12,41 | SEK | 21 643,04 | 2020-07-13 |
| 2020-07-17 | Stayble Therapeutics AB | Erik Kinnman | Styrelseledamot/suppleant | Acquisition | 2 572 | 12,41 | SEK | 31 918,52 | 2020-07-14 |
| 2020-07-17 | Stayble Therapeutics AB | Erik Kinnman | Styrelseledamot/suppleant | Acquisition | 3 415 | 12,41 | SEK | 42 380,15 | 2020-07-15 |
| 2021-02-04 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Gift given | 315 000 | 0 | SEK | 0 | 2021-02-03 |
| 2021-02-08 | Stayble Therapeutics AB | Mattias Münnich | Other member of the company's administrative, management or supervisory body | Gift given | 190 000 | 0 | SEK | 0 | 2021-02-02 |
| 2021-02-10 | Stayble Therapeutics AB | Anders Lehmann | Other member of the company's administrative, management or supervisory body | Gift given | 90 000 | 0 | SEK | 0 | 2021-02-07 |
| 2021-02-10 | Stayble Therapeutics AB | Patrik Sjöstrand | Member of the Board of Directors | Gift given | 257 683 | 0 | SEK | 0 | 2021-02-08 |
| 2021-02-12 | Stayble Therapeutics AB | Kjell Olmarker | Member of the Board of Directors | Gift given | 700 000 | 0 | SEK | 0 | 2021-02-09 |
| 2021-02-19 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Subscription | 15 000 | 6 | SEK | 90 000 | 2021-02-15 |
| 2021-02-22 | Stayble Therapeutics AB | Patrik Sjöstrand | Member of the Board of Directors | Subscription | 333 333 | 6 | SEK | 1 999 998 | 2021-02-16 |
| 2021-02-22 | Stayble Therapeutics AB | Catharina Bäärnhielm Marklund | Chairman of the Board of Directors | Acquisition | 4 000 | 6 | SEK | 24 000 | 2021-02-16 |
| 2021-04-22 | Stayble Therapeutics AB | Kjell Olmarker | Member of the Board of Directors | Disposal | 200 000 | 7,15 | SEK | 1 430 000 | 2021-04-07 |
| 2021-06-09 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Acquisition | 4 000 | 7,44 | SEK | 29 760 | 2021-06-08 |
| 2021-08-23 | Stayble Therapeutics AB | Sara Charlotta Richardson | Other senior executive | Acquisition | 8 215 | 8,52 | SEK | 69 991,8 | 2021-08-19 |
| 2021-08-31 | Stayble Therapeutics AB | Sara Charlotta Richardson | Other senior executive | Acquisition | 6 785 | 8,62 | SEK | 58 486,7 | 2021-08-26 |
| 2021-09-09 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Acquisition | 1 000 | 8,36 | SEK | 8 360 | 2021-09-08 |
| 2022-08-31 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 15 000 | 4,89 | SEK | 73 350 | 2022-08-30 |
| 2022-09-05 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Return of loan increase | 30 000 | 0 | SEK | 0 | 2022-08-31 |
| 2023-03-27 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Gift given | 81 401 | 0 | SEK | 0 | 2023-03-26 |